| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Cuervo et al. | no | yes: 0 | 
| Hassani et al. | no | yes: 0 | 
| Forrest at al. (metacyclic) | no | yes: 0 | 
| Forrest at al. (procyclic) | no | yes: 0 | 
| Silverman et al. | no | yes: 0 | 
| Pissara et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Pires et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Silverman et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| Jamdhade et al. | no | yes: 0 | 
| Source | Evidence on protein | Close homologs | 
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 9 | 
| NetGPI | no | yes: 0, no: 9 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0005929 | cilium | 4 | 10 | 
| GO:0042995 | cell projection | 2 | 10 | 
| GO:0043226 | organelle | 2 | 10 | 
| GO:0043227 | membrane-bounded organelle | 3 | 10 | 
| GO:0110165 | cellular anatomical entity | 1 | 10 | 
| GO:0120025 | plasma membrane bounded cell projection | 3 | 10 | 
| GO:0005737 | cytoplasm | 2 | 1 | 
Related structures:
AlphaFold database: A4IB70
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0006508 | proteolysis | 4 | 1 | 
| GO:0006807 | nitrogen compound metabolic process | 2 | 1 | 
| GO:0008152 | metabolic process | 1 | 1 | 
| GO:0019538 | protein metabolic process | 3 | 1 | 
| GO:0043170 | macromolecule metabolic process | 3 | 1 | 
| GO:0044238 | primary metabolic process | 2 | 1 | 
| GO:0071704 | organic substance metabolic process | 2 | 1 | 
| GO:1901564 | organonitrogen compound metabolic process | 3 | 1 | 
| Term | Name | Level | Count | 
|---|---|---|---|
| GO:0005488 | binding | 1 | 1 | 
| GO:0005515 | protein binding | 2 | 1 | 
| GO:0019899 | enzyme binding | 3 | 1 | 
| GO:0019900 | kinase binding | 4 | 1 | 
| GO:0019901 | protein kinase binding | 5 | 1 | 
| GO:0003824 | catalytic activity | 1 | 2 | 
| GO:0016787 | hydrolase activity | 2 | 2 | 
| GO:0004175 | endopeptidase activity | 4 | 1 | 
| GO:0004197 | cysteine-type endopeptidase activity | 5 | 1 | 
| GO:0008233 | peptidase activity | 3 | 1 | 
| GO:0008234 | cysteine-type peptidase activity | 4 | 1 | 
| GO:0140096 | catalytic activity, acting on a protein | 2 | 1 | 
| Leishmania | From | To | Domain/Motif | Score | 
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 275 | 279 | PF00656 | 0.414 | 
| CLV_NRD_NRD_1 | 112 | 114 | PF00675 | 0.747 | 
| CLV_NRD_NRD_1 | 232 | 234 | PF00675 | 0.560 | 
| CLV_PCSK_FUR_1 | 246 | 250 | PF00082 | 0.623 | 
| CLV_PCSK_KEX2_1 | 112 | 114 | PF00082 | 0.747 | 
| CLV_PCSK_KEX2_1 | 232 | 234 | PF00082 | 0.537 | 
| CLV_PCSK_KEX2_1 | 248 | 250 | PF00082 | 0.435 | 
| CLV_PCSK_PC1ET2_1 | 248 | 250 | PF00082 | 0.586 | 
| CLV_PCSK_SKI1_1 | 232 | 236 | PF00082 | 0.561 | 
| CLV_PCSK_SKI1_1 | 248 | 252 | PF00082 | 0.411 | 
| DEG_APCC_DBOX_1 | 84 | 92 | PF00400 | 0.557 | 
| DOC_CYCLIN_RxL_1 | 227 | 240 | PF00134 | 0.570 | 
| DOC_CYCLIN_RxL_1 | 244 | 254 | PF00134 | 0.585 | 
| DOC_MAPK_gen_1 | 244 | 253 | PF00069 | 0.535 | 
| DOC_MAPK_MEF2A_6 | 213 | 221 | PF00069 | 0.613 | 
| DOC_MAPK_MEF2A_6 | 23 | 30 | PF00069 | 0.407 | 
| DOC_USP7_MATH_1 | 169 | 173 | PF00917 | 0.659 | 
| DOC_USP7_MATH_1 | 294 | 298 | PF00917 | 0.563 | 
| DOC_USP7_MATH_1 | 65 | 69 | PF00917 | 0.480 | 
| DOC_USP7_MATH_1 | 93 | 97 | PF00917 | 0.556 | 
| DOC_USP7_UBL2_3 | 244 | 248 | PF12436 | 0.609 | 
| DOC_USP7_UBL2_3 | 257 | 261 | PF12436 | 0.522 | 
| DOC_WW_Pin1_4 | 22 | 27 | PF00397 | 0.484 | 
| LIG_14-3-3_CanoR_1 | 272 | 280 | PF00244 | 0.415 | 
| LIG_14-3-3_CanoR_1 | 92 | 98 | PF00244 | 0.568 | 
| LIG_Actin_WH2_2 | 266 | 283 | PF00022 | 0.520 | 
| LIG_BIR_III_4 | 178 | 182 | PF00653 | 0.696 | 
| LIG_BIR_III_4 | 240 | 244 | PF00653 | 0.522 | 
| LIG_BRCT_BRCA1_1 | 163 | 167 | PF00533 | 0.545 | 
| LIG_FHA_1 | 121 | 127 | PF00498 | 0.603 | 
| LIG_FHA_1 | 23 | 29 | PF00498 | 0.545 | 
| LIG_FHA_1 | 257 | 263 | PF00498 | 0.541 | 
| LIG_FHA_1 | 38 | 44 | PF00498 | 0.402 | 
| LIG_FHA_2 | 266 | 272 | PF00498 | 0.526 | 
| LIG_HP1_1 | 93 | 97 | PF01393 | 0.571 | 
| LIG_LIR_Gen_1 | 164 | 175 | PF02991 | 0.556 | 
| LIG_LIR_Gen_1 | 295 | 306 | PF02991 | 0.558 | 
| LIG_LIR_Nem_3 | 164 | 170 | PF02991 | 0.547 | 
| LIG_LIR_Nem_3 | 295 | 301 | PF02991 | 0.562 | 
| LIG_NRBOX | 230 | 236 | PF00104 | 0.504 | 
| LIG_PTB_Apo_2 | 102 | 109 | PF02174 | 0.427 | 
| LIG_PTB_Phospho_1 | 102 | 108 | PF10480 | 0.415 | 
| LIG_RPA_C_Fungi | 168 | 180 | PF08784 | 0.770 | 
| LIG_SH2_STAT5 | 24 | 27 | PF00017 | 0.579 | 
| LIG_Sin3_3 | 303 | 310 | PF02671 | 0.381 | 
| MOD_CDK_SPK_2 | 22 | 27 | PF00069 | 0.460 | 
| MOD_CK1_1 | 197 | 203 | PF00069 | 0.648 | 
| MOD_CK1_1 | 279 | 285 | PF00069 | 0.561 | 
| MOD_CK1_1 | 84 | 90 | PF00069 | 0.530 | 
| MOD_CK2_1 | 112 | 118 | PF00069 | 0.732 | 
| MOD_CK2_1 | 265 | 271 | PF00069 | 0.533 | 
| MOD_CK2_1 | 310 | 316 | PF00069 | 0.398 | 
| MOD_Cter_Amidation | 110 | 113 | PF01082 | 0.728 | 
| MOD_GlcNHglycan | 167 | 170 | PF01048 | 0.686 | 
| MOD_GlcNHglycan | 182 | 185 | PF01048 | 0.450 | 
| MOD_GlcNHglycan | 192 | 197 | PF01048 | 0.728 | 
| MOD_GlcNHglycan | 312 | 315 | PF01048 | 0.531 | 
| MOD_GlcNHglycan | 40 | 43 | PF01048 | 0.517 | 
| MOD_GSK3_1 | 107 | 114 | PF00069 | 0.641 | 
| MOD_GSK3_1 | 161 | 168 | PF00069 | 0.575 | 
| MOD_GSK3_1 | 169 | 176 | PF00069 | 0.565 | 
| MOD_GSK3_1 | 192 | 199 | PF00069 | 0.755 | 
| MOD_GSK3_1 | 272 | 279 | PF00069 | 0.547 | 
| MOD_GSK3_1 | 301 | 308 | PF00069 | 0.483 | 
| MOD_N-GLC_1 | 136 | 141 | PF02516 | 0.587 | 
| MOD_N-GLC_1 | 56 | 61 | PF02516 | 0.539 | 
| MOD_NEK2_1 | 107 | 112 | PF00069 | 0.659 | 
| MOD_NEK2_1 | 136 | 141 | PF00069 | 0.567 | 
| MOD_NEK2_1 | 204 | 209 | PF00069 | 0.699 | 
| MOD_NEK2_1 | 287 | 292 | PF00069 | 0.539 | 
| MOD_NEK2_1 | 305 | 310 | PF00069 | 0.319 | 
| MOD_NEK2_1 | 38 | 43 | PF00069 | 0.455 | 
| MOD_NEK2_1 | 70 | 75 | PF00069 | 0.424 | 
| MOD_NEK2_2 | 93 | 98 | PF00069 | 0.509 | 
| MOD_PIKK_1 | 120 | 126 | PF00454 | 0.619 | 
| MOD_PIKK_1 | 139 | 145 | PF00454 | 0.363 | 
| MOD_PIKK_1 | 204 | 210 | PF00454 | 0.731 | 
| MOD_PIKK_1 | 235 | 241 | PF00454 | 0.529 | 
| MOD_PKA_1 | 112 | 118 | PF00069 | 0.750 | 
| MOD_PKA_2 | 111 | 117 | PF00069 | 0.753 | 
| MOD_PKA_2 | 131 | 137 | PF00069 | 0.579 | 
| MOD_PKA_2 | 6 | 12 | PF00069 | 0.570 | 
| MOD_PKA_2 | 84 | 90 | PF00069 | 0.527 | 
| MOD_Plk_1 | 294 | 300 | PF00069 | 0.496 | 
| MOD_Plk_1 | 56 | 62 | PF00069 | 0.566 | 
| MOD_Plk_2-3 | 56 | 62 | PF00069 | 0.534 | 
| MOD_Plk_4 | 1 | 7 | PF00069 | 0.430 | 
| MOD_Plk_4 | 199 | 205 | PF00069 | 0.735 | 
| MOD_Plk_4 | 301 | 307 | PF00069 | 0.467 | 
| MOD_Plk_4 | 65 | 71 | PF00069 | 0.435 | 
| MOD_ProDKin_1 | 22 | 28 | PF00069 | 0.475 | 
| MOD_SUMO_rev_2 | 238 | 245 | PF00179 | 0.578 | 
| TRG_DiLeu_BaEn_1 | 230 | 235 | PF01217 | 0.478 | 
| TRG_DiLeu_LyEn_5 | 230 | 235 | PF01217 | 0.502 | 
| TRG_ER_diArg_1 | 231 | 233 | PF00400 | 0.574 | 
| TRG_Pf-PMV_PEXEL_1 | 249 | 254 | PF00026 | 0.510 | 
| Protein | Taxonomy | Sequence identity | Coverage | 
|---|---|---|---|
| A0A0N0P4E0 | Leptomonas seymouri | 51% | 74% | 
| A0A0S4KH47 | Bodo saltans | 27% | 83% | 
| A0A1X0P5U4 | Trypanosomatidae | 33% | 88% | 
| A0A3Q8IF21 | Leishmania donovani | 99% | 72% | 
| A0A422NQ71 | Trypanosoma rangeli | 35% | 88% | 
| A4HMJ0 | Leishmania braziliensis | 81% | 100% | 
| C9ZZH9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 88% | 
| E9AEZ1 | Leishmania major | 88% | 100% |